Foundayo (orforglipron), an oral GLP-1 alternative, provides flexible dosing without meal timing constraints
Both formulations are administered as intramuscular injections, usually weekly, as part of a medically-supervised weight loss protocol that includes caloric restriction and, increasingly, GLP-1 receptor agonist therapy like semaglutide or tirzepatide
Persistent numbness or weakness after an injection should always be reviewed by a doctor
When gut health is compromised, Treg production may decrease, contributing to the excessive immune reactivity that characterizes eczema
Tips for minimizing discomfort To reduce side effects when transitioning: Eat smaller meals Avoid fatty foods when symptoms are present Stay well hydrated Follow your doctor's dose escalation schedule precisely Don't increase your dose faster than recommended, even if you feel good Take the medication on the same day each week If you experience severe or persistent side effects, contact your healthcare provider promptly